Hudson Bay Capital Management LP lifted its stake in ChampionX Co. (NASDAQ:CHX - Free Report) by 186.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 964,420 shares of the company's stock after purchasing an additional 627,426 shares during the quarter. Hudson Bay Capital Management LP owned about 0.51% of ChampionX worth $26,223,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CHX. Jones Financial Companies Lllp lifted its position in ChampionX by 153.2% in the 4th quarter. Jones Financial Companies Lllp now owns 924 shares of the company's stock valued at $25,000 after acquiring an additional 559 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in shares of ChampionX by 1,051.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,889 shares of the company's stock valued at $51,000 after purchasing an additional 1,725 shares in the last quarter. R Squared Ltd purchased a new stake in shares of ChampionX during the fourth quarter valued at $103,000. Vestcor Inc increased its holdings in ChampionX by 71.6% in the 4th quarter. Vestcor Inc now owns 5,032 shares of the company's stock worth $137,000 after buying an additional 2,100 shares in the last quarter. Finally, Brown Brothers Harriman & Co. raised its position in ChampionX by 82,557.1% in the 4th quarter. Brown Brothers Harriman & Co. now owns 5,786 shares of the company's stock worth $157,000 after buying an additional 5,779 shares during the last quarter. Institutional investors own 98.99% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Stifel Nicolaus lifted their price target on shares of ChampionX from $39.00 to $40.00 and gave the stock a "buy" rating in a research note on Monday, May 5th.
Read Our Latest Stock Analysis on ChampionX
ChampionX Stock Up 0.6 %
ChampionX stock opened at $25.10 on Friday. ChampionX Co. has a one year low of $21.92 and a one year high of $35.94. The stock has a fifty day moving average of $26.68 and a 200 day moving average of $28.28. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.36 and a current ratio of 1.99. The stock has a market cap of $4.81 billion, a PE ratio of 15.21 and a beta of 1.52.
ChampionX (NASDAQ:CHX - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.41 by $0.09. The firm had revenue of $864.46 million during the quarter, compared to analyst estimates of $900.59 million. ChampionX had a net margin of 8.81% and a return on equity of 19.84%. The business's revenue for the quarter was down 6.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.50 EPS. As a group, sell-side analysts predict that ChampionX Co. will post 1.92 EPS for the current year.
ChampionX Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Thursday, July 3rd will be given a dividend of $0.095 per share. This represents a $0.38 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date of this dividend is Thursday, July 3rd. ChampionX's payout ratio is 25.17%.
ChampionX Company Profile
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
See Also
Want to see what other hedge funds are holding CHX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ChampionX Co. (NASDAQ:CHX - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
